AR and cancer: Further, ACK1 also phosphorylates ATP synthase F1 subunit α (ATP5F1A) in CRPC,126 and (R)-9b treatment not only significantly compromised AR transcriptional activity, but also mitigated increased mitochondrial energy output in cancer, diminishing prostate tumor growth.